Nachrichten zur Moderna Aktie

Moderna Aktie: Ein Silberstreif - Chartanalyse

Düsseldorf (www.aktiencheck.de) - Moderna-Chartanalyse von HSBC Trinkaus & Burkhardt: Die Analysten von HSBC Trinkaus & Burkhardt nehmen in einer aktuellen Aktienanalyse…

MRNA Stock Jumps on CDCs Revised RSV Vaccine Recommendations

Moderna rises as CDC expands RSV vaccine guidance to include high-risk adults aged 50-59, boosting mResvias reach.…

Got $200? 2 Biotech Stocks to Buy and Hold Forever

Some potential investors hesitate to get started on building an investment portfolio because they think they need thousands of dollars…

Top Stock Movers Now: Hewlett Packard Enterprise, Moderna, Tesla, and More

The S&P 500 and Nasdaq added to their all-time highs at midday as investors anticipated more U.S. trade agreements ahead.…

Modernas flu vaccine shows positive late-stage trial results, paving way for combination Covid shot

The phase three study data clears the path forward for Modernas combination jab targeting Covid-19 and influenza.…

Moderna (MRNA) Outperforms Broader Market: What You Need to Know

In the closing of the recent trading day, Moderna (MRNA) stood at $27.54, denoting a +2.53% move from the preceding…

Moderna (MRNA) Advances While Market Declines: Some Information for Investors

In the most recent trading session, Moderna (MRNA) closed at $25.90, indicating a +1.97% shift from the previous trading day.…

Moderna, Inc. (MRNA) Presents at Barclays Speaking the Science Call Series Transcript

…

Moderna falls on fears new CDC vaccine advisory panel could cloud RSV shot prospects By Reuters

Moderna falls on fears new CDC vaccine advisory panel could cloud RSV shot prospects…

Moderna falls on fears new CDC vaccine advisory panel could cloud RSV shot prospects

Modernas shares fell 2.5% before the bell on Friday, on concerns whether a new CDC advisory panel would back the…

US FDA approves expanded use of Moderna’s RSV vaccine for at-risk adults By Reuters

US FDA approves expanded use of Moderna’s RSV vaccine for at-risk adults…

Moderna, Inc. (MRNA) Presents at Goldman Sachs 46th Annual Global Healthcare Conference Transcript

…

Blitz-Update Wall Street: Nike, Tesla, Apple im Aufwind, T-Mobile, BioNTech, Moderna unter Druck

An den US-Börsen ist in den ersten Handelsstunden nur wenig Bewegung zu beobachten. Der Leitindex Dow Jones notiert gut zwei…

Blitz-Update Wall Street: Nike, Tesla, Apple im Aufwind, T-Mobile, BioNTech, Moderna unter Druck

An den US-Börsen ist in den ersten Handelsstunden nur wenig Bewegung zu beobachten. Der Leitindex Dow Jones notiert gut zwei…

BioNTech, Moderna und Co im Fokus: Kennedy greift durch

Nächster Paukenschlag in den USA: Gesundheitsminister Robert F. Kennedy Jr. hat alle Mitglieder eines Gremiums (ACIP) von Impfexperten der US-…

Moderna, Pfizer, and BioNTech stocks dip on vaccine panel overhaul By Investing.com

Moderna, Pfizer, and BioNTech stocks dip on vaccine panel overhaul…

Moderna, Inc. (MRNA) Presents at Jefferies Global Healthcare Conference Transcript

…

Moderna agrees to true placebo-controlled trial of new COVID vaccine, Kennedy says By Reuters

Moderna agrees to true placebo-controlled trial of new COVID vaccine, Kennedy says…

FDA grants limited approval to Moderna’s new mRNA COVID vaccine By Investing.com

FDA grants limited approval to Moderna’s new mRNA COVID vaccine…

Moderna: Vaccine Approval (Finally!) Provides A Reason To Be Cheerful

…

Stocks making the biggest premarket moves: Cleveland-Cliffs, Nucor, Moderna, Tesla and more

These are the stocks posting the largest moves in the premarket.…

Moderna moves higher on FDA approval of new COVID-19 vaccine

Moderna Inc (NASDAQ:MRNA, ETR:0QF) shares edged higher after the US Food and Drug Administration (FDA) approved its newest COVID-19 vaccine…

FDA approves Modernas new lower-dose Covid-19 vaccine

The U.S. approved a new Covid-19 vaccine made by Moderna but with limits on who can use it — not…

Moderna, Inc. (MRNA) Bernstein 41st Annual Strategic Decisions Conference Call Transcript

…

Moderna at Bernstein Conference: Strategic Diversification Plans By Investing.com

Moderna at Bernstein Conference: Strategic Diversification Plans…

Trump administration cancels $766 million Moderna contract to fight pandemic flu

The Trump administration canceled $766 million awarded to Moderna Inc. to develop a vaccine against potential pandemic influenza viruses, including…

U.S. Govt. Cancels $766M Funding Contract for Modernas Bird Flu Shot

The government scraps funding deal for MRNAs bird flu shot, despite encouraging safety and efficacy data from early clinical studies…

Moderna Aktienanalyse: Trump-Administration kündigt H5N1-Impfstoffvertrag - Analysten uneins

Bad Marienberg (www.aktiencheck.de) - Die jüngste Entscheidung der US-Regierung, einen Vertrag über insgesamt 766 Millionen USD mit Moderna Inc. (ISIN:…

US cancels more $700 million funding for Moderna bird flu vaccine By Reuters

US cancels more $700 million funding for Moderna bird flu vaccine…

US cancels more $700 million funding for Moderna bird flu vaccine

The Trump administration has cancelled a contract awarded to Moderna for the late-stage development of its bird flu vaccine for…

MRNA Seeks FDA Nod for Updated COVID-19 Vaccine

Moderna files with FDA for updated Spikevax aimed at the LP.8.1 variant, which makes up 70% of U.S. COVID-19 cases.…

Moderna files application for updated COVID vaccine By Reuters

Moderna files application for updated COVID vaccine…

Moderna files application for updated COVID vaccine

Moderna said on Friday it had filed a marketing application for an updated COVID vaccine to the U.S. Food and…

MRNA Stock Down on Withdrawal of FDA Filing for COVID-Flu Combo Shot

Modernas voluntary withdrawal of the filing stems from the FDAs request for vaccine efficacy data from a phase III study…

MRNA, PFE Stocks Jump Despite FDAs Stricter Standards for COVID-19 Shots

Though the new FDA rules limit access to COVID-19 booster vaccines, the commitment to high-risk groups lifts Moderna, Pfizer and…

Stocks making the biggest moves midday: D-Wave Quantum, Moderna, Agilysys, Tesla and more

These are some of the stocks posting the largest moves in midday trading.…

Moderna: After A Crash From $500 To $25, Im Buying This "Call Option" On Pandemics And Cancer

…

Moderna shares surge as new FDA vaccine framework eases investor concerns

Moderna Inc (NASDAQ:MRNA, ETR:0QF) shares jumped more than 6.5% on Tuesday after the US Food and Drug Administration unveiled a…

Lag B’Omer’s lessons for responsible investing

Modern commerce still runs on the most volatile of fuels: human motivation.…

Moderna Sharpens Pipeline Focus as COVID-19 Vaccine Demand Ebbs in Q1

Moderna plans to launch 10 new marketed products over the next three years, aiming to diversify a revenue base, which…

Moderna faces long-term threat from NIH’s universal vaccine initiative, Jefferies says

Moderna Inc (NASDAQ:MRNA, ETR:0QF) could face a longer-term threat from a newly announced US government initiative to develop universal vaccines…

Moderna (MRNA) Reports Q1 Earnings: What Key Metrics Have to Say

The headline numbers for Moderna (MRNA) give insight into how the company performed in the quarter ended March 2025, but…

Moderna: Regulatory Hurdles And Market Challenges Prompt Downgrade To Sell

…

Moderna Beats on Q1 Earnings, Lags on Revenues, Focuses on Cost Cuts

MRNA reports mixed Q1 results. The company reiterates 2025 sales guidance but announces a cost-cutting initiative to reduce expenses significantly…

Moderna beats Wall Street estimates for first-quarter profit and sales

Moderna on Thursday reported first-quarter profit and sales that beat Wall Street estimates, helped by the companys cost-cutting efforts following…

Moderna Aktie unter Druck - Zölle, Patentabläufe und IRA-Risiken im Fokus

London (www.aktiencheck.de) - Moderna-Aktienanalyse von HSBC: Aktuelle Bewertung HSBC hat das Kursziel für Moderna Inc. (ISIN: US60770K1079, WKN: A2N9D9, Ticker-Symbol: 0QF, NASDAQ-Symbol:…

Moderna Aktie: Politischer Gegenwind

New York (www.aktiencheck.de) - Moderna-Aktienanalyse von Sanford C. Bernstein & Co: 1. Hintergrund Bernstein hat das Kursziel für die Aktie von Moderna…

Down 36%, Is Moderna a Buy on the Dip?

In many ways, the pandemic is becoming a faded memory. With that, a major pandemic star -- biotech Moderna (NASDAQ:…

Down 36%, Is Moderna a Buy on the Dip? @themotleyfool #stocks $MRNA

…

Market Sell-Off: 2 Stocks Down 17% and 36% This Year to Buy and Hold

What should investors do during a stock-market correction? One great strategy is to go shopping. A bull market will eventually…